MPT0L145 is a first-in-class PIK3C3/FGFR inhibitor. References: Chen CH, Liu YM, Pan SL, Liu YR, Liou JP, Yen Y. Trichlorobenzene-substituted azaaryl compounds as novel FGFR inhibitors exhibiting potent antitumor activity in bladder cancer cells in vitro and in vivo. Oncotarget. 2016 May 3;7(18):26374-87. doi: 10.18632/oncotarget.8380. PubMed PMID: 27029060; PubMed Central PMCID: PMC5041986.

纯度：≥98%

CAS：2070837-24-8